Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
5 minutes with... Kate Lenik, Chiesi
Kate Lenik shares her journey into HR, the evolving pharma workplace, and the secrets behind Chiesi’s award-winning culture.
Read more
Elevating pharma’s parental leave policies
With continued drive for equality across the pharma industry, the issue of parental leave is coming to the fore. But is the industry’s approach sufficiently transparent, and what more can be done?
Driving post-conference motivation in pharma: a how-to guide
How can pharma embrace post-conference momentum?
The emergence of digital twins
What is a digital twin and how do they benefit pharma?
Going the extra mile for women's health
How can pharma boost R&D efforts into women’s health issues?
Decentralised clinical trials: going green
Decentralised clinical trials are held in high regard in terms of climate impact, but are they as sustainable as they seem?
Tackling the trust gap in genomic medicine
How can pharma tackle public mistrust in genomic medicine?
Reframing pharma's bad boy reputation
The pharmaceutical industry is a rich source of material for the small screen, but why is it framed as the perpetual bad boy?
Sanofi’s Dr Juby Jacob-Nara on medical affairs and mentorship
How does a physician make a difference in medical affairs? Juby Jacob-Nara tells her story.
Loading posts...
« Previous
1
…
13
14
15
16
17
…
33
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View